Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature

Orna Diav-Citrin, Laura Hunnisett, Graham D. Sher, Gideon Koren

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء

58 اقتباسات (Scopus)

ملخص

A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malformations. A literature review, including this case, suggests that the risk of hydroxyurea exposure during in pregnancy may have been overestimated. Further studies are required to determine its safety in pregnancy.

اللغة الأصليةالإنجليزيّة
الصفحات (من إلى)148-150
عدد الصفحات3
دوريةAmerican Journal of Hematology
مستوى الصوت60
رقم الإصدار2
المعرِّفات الرقمية للأشياء
حالة النشرنُشِر - 1999
منشور خارجيًانعم

بصمة

أدرس بدقة موضوعات البحث “Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا